---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-25-008932"
form_type: "8-K"
ticker: "VNRX"
cik: "0000093314"
company_name: "VOLITIONRX LTD"
filed_at: "2025-12-11T23:59:59+00:00"
generated_at: "2026-05-16T13:36:40.026299+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# VolitionRx subsidiary CEO Dr. Butera to depart Jan 31, 2026; position eliminated

## Summary
- Volition Veterinary CEO Dr. Salvatore Thomas Butera given termination notice, effective Jan 31, 2026.
- CEO position eliminated as part of ongoing cost-realignment efforts; duties redistributed.
- Dr. Butera expected to stay as part-time consultant post-termination under agreed terms.
- Departure not due to any disagreement with company on operations, policies, or practices.

## SEC filing metadata
- accession: 0001477932-25-008932
- form_type: 8-K
- ticker: VNRX
- cik: 0000093314
- company_name: VOLITIONRX LTD
- filed_at: 2025-12-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/93314/000147793225008932/0001477932-25-008932-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/93314/000147793225008932/vnrx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-25-008932
- JSON: https://secwatch.observer/filing/0001477932-25-008932.json
- Plain text: https://secwatch.observer/filing/0001477932-25-008932.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.